Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.

被引：0
|
作者：
Broto, Javier Martin
Marcilla, David
Ramos, Rafael
Moura, David Silva
Alvarez, Ramiro
Hernandez, Nieves
Pujol, Carolina Agra
Mayordomo, Empar
Romagosa, Cleofe
Bague, Silvia
Reguero, Eugenia
Cruz, Julia
Martin, Francisco Javier
Gutierrez, Antonio
Cruz, Josefina
Alvarez, Rosa Maria Alvarez
Beveridge, Robert Diaz
Morales, Claudia Maria Valverde
Lopez-Pousa, Antonio
Martinez-Trufero, Javier
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11071
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Retrospective analysis of surgery in metastatic GIST patients sensitive to imatinib: A Spanish Group for Research on Sarcoma (GEIS) study.
    Rubio, J.
    Martinez-Trufero, J.
    Lopez-Pousa, A.
    Garcia del Muro, X.
    Fra, J.
    Redondo, A.
    Lainez, N.
    Poveda, A.
    Casado, A.
    Valverde, C. M.
    De Juan, A.
    Sevilla, I.
    Andres, R.
    Cruz, J.
    Safont, M. J.
    Martin Broto, J.
    Garcia-Albeniz, X.
    Maurel, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] The role of trabectedin as second-line treatment of advanced soft tissue sarcoma: update of key efficacy and safety data
    Le Cesne, Axel
    FUTURE ONCOLOGY, 2022, 18 (30S) : 1 - 3
  • [33] Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase II trial in localized myxoid liposarcoma-A collaborative Spanish (GEIS), Italian (ISG) and French (FSG) group study.
    Gronchi, Alessandro
    Hindi, Nadia
    Blay, Jean-Yves
    Redondo, Andres
    Sanfilippo, Roberta
    Morosi, Carlo
    Jurado, Josefina Cruz
    Fra, Pablo Luna
    Martinez-Trufero, Javier
    Morales, Claudia Maria Valverde
    Romero, Jesus
    Peinado, Javier
    Sangalli, Claudia
    Sunyach, Marie Pierre
    Romagosa, Cleofe
    Ranchere-Vince, Dominique
    Gutierrez, Antonio
    De Tos, Paolo
    Broto, Javier Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Randomized phase II trial of doxorubicin vs. trabectedin plus doxorubicin in first line treatment of patients with advanced non-resectable or metastatic soft tissue sarcomas: a Spanish Group for Sarcoma Research (GEIS) study
    Martin-Broto, J.
    Lopez-Pousa, A.
    Garcia del Muro, X.
    De Las Penas, R.
    Martinez-Trufero, J.
    Cruz, J.
    Alvarez, R.
    Cubedo, R.
    Redondo, A.
    Poveda, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S875 - S875
  • [35] Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II
    Martinez-Trufero, Javier
    Jurado, Josefina Cruz
    Hernandez-Leon, C. Nieves
    Correa, Raquel
    Asencio, Jose Manuel
    Bernabeu, Daniel
    Alvarez, Rosa
    Hindi, Nadia
    Mata, Cristina
    Marquina, Gloria
    Martinez, Virginia
    Redondo, Andres
    Floria, Luis Javier
    Gomez-Mateo, M. Carmen
    Lavernia, Javier
    Sebio, Ana
    del Muro, Xavier Garcia
    Martin-Broto, Javier
    Valverde-Morales, Claudia
    CANCER TREATMENT REVIEWS, 2021, 99
  • [36] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    J. Martín-Liberal
    A. López-Pousa
    J. Martín Broto
    R. Cubedo
    O. Gallego
    E. Brendel
    O. M. Tirado
    X. García del Muro
    Investigational New Drugs, 2014, 32 : 287 - 294
  • [37] MAPPING THE LITERATURE: ROLE OF TRABECTEDIN AS A NEW CHEMOTHERAPY OPTION IN ADVANCED PRETREATED SOFT TISSUE SARCOMA
    Le Cesne, A.
    Domont, J.
    Cioffi, A.
    Bonvalot, S.
    Terrier, P.
    Ray-Coquard, I.
    Alfaro, V.
    Lebedinsky, C.
    Santabarbara, P.
    Blay, J. Y.
    DRUGS OF TODAY, 2009, 45 (06) : 403 - 421
  • [38] Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes
    Grignani, Giovanni
    Le Cesne, Axel
    Martin-Broto, Javier
    FUTURE ONCOLOGY, 2022, 18 (30S) : 13 - 22
  • [39] Phase II trial of temozolomide as first-line treatment for patients with advanced gynecological sarcoma: A Spanish Group for Research on Sarcomas (GEIS) and Spanish Ovarian Cancer Research Group (GEICO) study.
    Del Muro, X. Garcia
    Poveda, A.
    Buesa, J. M.
    Trufero, J. Martinez
    De Sande, L. M.
    Calvo, E.
    Escudero, P.
    Pousa, A. Lopez
    Fabregat, X.
    Casado, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 537S - 537S
  • [40] Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase I/II trial-A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) groups study.
    Gronchi, Alessandro
    Hindi, Nadia
    Cruz, Josefina
    Blay, Jean-Yves
    Sanfilippo, Roberta
    Morosi, Carlo
    Romero, Jesus
    Peinado, Javier
    Lopez-Pousa, Antonio
    Alvarez, Rosa Maria Alvarez
    Italiano, Antoine
    Perez, Jose Luis
    Sartgalli, Claudia
    Sunyach, Marie Pierre
    Romagosa, Cleofe
    Ranchere-Vince, Dominique
    Collini, Paola
    Broto, Javier Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345